Tag Archives: Biosimilars

Increased Payer and Provider Support May Drive Billions of Dollars in Savings from Biosimilars

By SHEILA FRAME  FDA Commissioner Scott Gottlieb has said biosimilars are “key to promoting access and reducing health care costs. And it’s a key to advancing public health.” While the Administration works to reduce barriers to bringing biosimilars to market, payers and providers can help increase adoption of biosimilars in clinical practice and ensure cost… Read More »